MX1 and leukemia: The in vivo expansion of leukemia was markedly reduced in triple transgenic mice where KRAS was expressed in hematopoietic cells of animals with genetic NOX2 deficiency (Nox2−/− × LSL-KrasG12D × Mx1-Cre).